Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% above its 5-year average of -1036.31%, near the high end of its 5-year range (-26566.67%–8.49%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
-714.74%
GROSS MARGIN AVG 5Y
-1036.31%
GROSS MARGIN AVG 10Y
-811.30%
GROSS MARGIN AVG 15Y
-77.97%
GROSS MARGIN AVG 20Y
-34.91%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 715 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
BioCardia, Inc.
Market Cap
$16.08M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-714.74%
5Y Avg
-1036.31%
Market Cap
$15.81M
Gross Margin
107.54%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
16.67%
Market Cap
$16.49M
Gross Margin
-88.25%
TTM Avg
-11.22%
3Y Avg
9.24%
5Y Avg
11.19%
Market Cap
$16.73M
Gross Margin
99.63%
TTM Avg
49.76%
3Y Avg
72.18%
5Y Avg
92.05%
Market Cap
$16.74M
Gross Margin
21.95%
TTM Avg
11.59%
3Y Avg
17.76%
5Y Avg
20.87%
Market Cap
$15.30M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-33.27%
Market Cap
$15.25M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-2.45%
Market Cap
$17.13M
Gross Margin
0.00%
TTM Avg
-52.16%
3Y Avg
-139.89%
5Y Avg
-776.52%
Market Cap
$15.07M
Gross Margin
95.88%
TTM Avg
95.90%
3Y Avg
96.27%
5Y Avg
96.83%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $16.08M | 0.00% | 0.00% | -714.74% | -1036.31% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.81M | 107.54% | 50.00% | 25.00% | 16.67% |
| Dyadic International, Inc. (DYAI)vs › | $16.49M | -88.25% | -11.22% | 9.24% | 11.19% |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | 99.63% | 49.76% | 72.18% | 92.05% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.74M | 21.95% | 11.59% | 17.76% | 20.87% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 0.00% | 0.00% | 0.00% | -33.27% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.25M | 0.00% | 0.00% | 0.00% | -2.45% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.13M | 0.00% | -52.16% | -139.89% | -776.52% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.07M | 95.88% | 95.90% | 96.27% | 96.83% |
| Lipocine Inc. (LPCN)vs › | $17.15M | -334.26% | -117.13% | -347.18% | -222.70% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -26566.67% |
| 2024-03-31 | -2156.36% |
| 2023-12-31 | -8792.31% |
| 2023-09-30 | -424.37% |
| 2023-06-30 | -5281.40% |
| 2023-03-31 | -3625.00% |
| 2022-12-31 | 8.49% |
| 2022-09-30 | -911.32% |
| 2022-06-30 | -136.55% |
| 2022-03-31 | -3543.33% |
| 2021-12-31 | -124.05% |
| 2021-09-30 | -172.84% |
| 2021-06-30 | -3323.19% |
| 2021-03-31 | -3902.17% |
| 2020-12-31 | -4954.35% |
| 2020-09-30 | -7176.47% |
| 2020-06-30 | -8137.04% |
| 2020-03-31 | -278.95% |
| 2019-12-31 | 13.95% |
| 2019-09-30 | 87.63% |
| 2019-06-30 | -122.09% |
| 2019-03-31 | 50.93% |
| 2018-12-31 | -12.62% |
| 2018-09-30 | -29.76% |
| 2018-06-30 | 43.51% |
| 2018-03-31 | 21.11% |
| 2017-12-31 | -65.00% |
| 2017-09-30 | -13.08% |
| 2017-06-30 | -81.25% |
| 2017-03-31 | -27.74% |
| 2016-12-31 | 113.03% |
| 2016-09-30 | 3948.72% |
| 2016-06-30 | -359.86% |
| 2016-03-31 | -347.65% |
| 2015-12-31 | -300.00% |
| 2015-09-30 | -520.66% |
| 2015-06-30 | -448.00% |
| 2015-03-31 | -343.38% |
| 2014-12-31 | 100.00% |
| 2014-09-30 | 100.00% |
| 2014-06-30 | 100.00% |
| 2014-03-31 | -639.80% |
| 2013-12-31 | 100.00% |
| 2013-09-30 | 100.00% |
| 2013-06-30 | 100.00% |
| 2013-03-31 | 100.00% |
| 2012-12-31 | 100.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 20.65% |
| 2010-09-30 | -132.04% |
| 2010-06-30 | 79.48% |
| 2010-03-31 | 80.93% |
| 2009-12-31 | 77.30% |
| 2009-09-30 | 80.73% |
| 2009-06-30 | 80.27% |
| 2009-03-31 | 81.02% |
| 2008-12-31 | 82.74% |
| 2008-09-30 | 83.94% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 77.91% |
| 2004-09-30 | 78.36% |
| 2004-06-30 | 77.12% |
| 2004-03-31 | 77.86% |
| 2003-12-31 | 75.64% |
| 2003-09-30 | 77.89% |
| 2003-06-30 | 72.06% |
| 2003-03-31 | 77.31% |
| 2002-12-31 | 76.13% |
| 2002-09-30 | 76.95% |
